Hemanext Inc. — Form D/A

Hemanext Inc. of LEXINGTON, MA, a company, filed a Form D amendment with the SEC on 2021-10-15. The offering totals $59.5M, of which $39.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (57)

Showing 25 of 57 people.

NameRoleLocation
Jill Patrick BuckleyExecutive OfficerLexington, MA
Laura Patrick DanielsExecutive OfficerLexington, MA
Andrew Patrick DunhamExecutive OfficerLexington, MA
Robert Patrick HaimeExecutive OfficerLexington, MA
Alex Patrick MarichalExecutive OfficerLexington, MA
Eric Patrick NewmanExecutive OfficerLexington, MA
Laurel Patrick OmertExecutive OfficerLexington, MA
Eric NewmanExecutive OfficerPalm Beach Gardens, FL
Robert J HaimeExecutive OfficerLexington, MA
Eric J NewmanExecutive OfficerLexington, MA
Peter A TestaDirectorLexington, MA
Daan M KokExecutive OfficerLexington, MA
Paul M NessDirectorLexington, MA
Geoffrey M CrouseDirectorLexington, MA
Andrew DunhamDirectorLexington, MA
Andrew DunhamExecutive OfficerLexington, MA
Laura J DanielsExecutive OfficerLexington, MA
Eduardo Patrick AvayuDirectorLexington, MA
Philip M PeadDirectorLexington, MA
Stephen A EckertDirectorLexington, MA
Joseph M GroganDirectorLexington, MA
Laurel J OmertExecutive OfficerLexington, MA
Ismail M KolaDirectorLexington, MA
William Patrick O'NeillDirectorLexington, MA
Jill J BuckleyExecutive OfficerLexington, MA

Other filings by this issuer (12)

FiledFormOfferingSold
2025-08-05D$24.0M$20.0M
2025-07-31D$21.7M$21.7M
2024-01-08D$10.0M$5.0M
2023-11-08D$11.3M$11.3M
2023-02-07D$15.0M$13.2M
2020-10-23D/A$44.5M$21.2M
2019-10-25D$14.5M$4.4M
2018-10-26D/A$16.0M$8.8M
2018-02-06D$2.5M$2.0M
2017-12-19D$5.0M$2.7M
2016-12-20D
2013-12-16D$17.6M$12.3M

More